3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases -> Monitor Keywords
Fresh Patents
Monitor Patents Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents Browse Locations
site info Site News  |  monitor Monitor Keywords  |  monitor archive Monitor Archive  |  organizer Organizer  |  account info Account Info  |  
06/05/08 - USPTO Class 514 |  48 views | #20080132556 | Prev - Next | About this Page  514 rss/xml feed  monitor keywords

3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases

USPTO Application #: 20080132556
Title: 3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases
Abstract: wherein the groups R1, X and Y may have the meanings given in the claims and in the specification, for preparing a pharmaceutical composition for the treatment of COPD (chronic obstructive pulmonary disease), as well as new compounds of general formula 1 and processes for preparing them. The present invention relates to the use of the compounds of general formula 1 (end of abstract)



Agent: Michael P. Morris Boehringer Ingelheim Corporation - Ridgefield, CT, US
Inventors: Thierry Bouyssou, Frank Buettner, Ingo Konetzki, Sabine Pestel, Andreas Schnapp, Hermann Schollenberger, Kurt Schromm, Claudia Heine
USPTO Applicaton #: 20080132556 - Class: 514381 (USPTO)

3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases description/claims


The Patent Description & Claims data below is from USPTO Patent Application 20080132556, 3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases.

Brief Patent Description - Full Patent Description - Patent Application Claims
  monitor keywords

The present invention relates to compounds of general formula 1

wherein the groups R1, X and Y may have the meanings given in the claims and in the specification, processes for preparing them and their use as pharmaceutical compositions, particularly for the treatment of inflammatory and obstructive respiratory complaints.

BACKGROUND TO THE INVENTION

Betamimetics (β-adrenergic substances) are known from the prior art. In this respect reference is made for example to the disclosure of U.S. Pat. No. 4,647,563, which proposes betamimetics for the treatment of a wide range of diseases.

For the drug treatment of diseases it is often desirable to prepare medicaments with a longer duration of activity. As a rule, this ensures that the concentration of the active substance in the body needed to achieve the therapeutic effect is guaranteed for a longer period without the need to re-administer the drug at frequent intervals. Moreover, giving an active substance at longer time intervals contributes to the wellbeing of the patient to a high degree. It is particularly desirable to prepare a pharmaceutical composition which can be used therapeutically by administration once a day (single dose). The use of a drug once a day has the advantage that the patient can become accustomed relatively quickly to regularly taking the drug at certain times of the day.

The aim of the present invention is therefore to provide betamimetics which are characterised by a longer duration of activity and can thus be used to prepare pharmaceutical compositions with a longer duration of activity. A particular aim of the invention is to prepare betamimetics which, by virtue of their long-lasting effect, can be used to prepare a drug for administration once a day. A further objective of the invention is to prepare new betamimetics which, by virtue of their long-lasting effect, can be used to prepare a drug for administration once a day for the treatment of inflammatory or obstructive respiratory complaints.

In addition to the above objectives, the present invention also sets out to provide betamimetics which are not only exceptionally potent but are also characterised by a high degree of selectivity with respect to the β2-adreno-receptor.

DETAILED DESCRIPTION OF THE INVENTION

Surprisingly it has been found that the above-mentioned objectives are achieved by compounds of general formula 1.

Accordingly, the present invention relates to compounds of general formula 1

wherein X denotes nitrogen, oxygen or CR2;

Continue reading about 3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases...
Full patent description for 3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases

Brief Patent Description - Full Patent Description - Patent Application Claims

Click on the above for other options relating to this 3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases patent application.
###
monitor keywords

How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like 3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases or other areas of interest.
###


Previous Patent Application:
Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
Next Patent Application:
Preparation and utility of substituted phenyltetrazoles
Industry Class:
Drug, bio-affecting and body treating compositions

###

FreshPatents.com Support
Thank you for viewing the 3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases patent info.
IP-related news and info


Results in 0.24887 seconds


Other interesting Feshpatents.com categories:
Daimler Chrysler , DirecTV , Exxonmobil Chemical Company , Goodyear , Intel , Kyocera Wireless , 174
filepatents (1K)

* Protect your Inventions
* US Patent Office filing
patentexpress PATENT INFO